Tag: agglutinin
Press release: European Commission approves Enjaymo® (sutimlimab) for the treatment of hemolytic anemia in adults with cold agglutinin disease – 11/17/2022 at 6:50 p.m.
The European Commission approves Enjaymo ® (sutimlimab) for treatment of hemolytic anemia in adults suffering from cold agglutinin disease Enjaymo is the first and only approved treatment option for the…
Sanofi: FDA approves Enjaymo to treat cold agglutinin disease
PARIS (Agefi-Dow Jones)–The pharmaceutical group Sanofi announced Friday evening that the Food and drug administration (FDA), the American health authority, had approved its drug Enjaymo, to reduce the use of…